Treatment For Dry Eyes

The Leading Cause of Dry Eyes:
Meibomian Gland Disease (MGD)

The eyelids are lined with meibomian glands that release important lubricants to the eye. Without these oils, the eyes become more vulnerable to the adverse effects of our daily habits or environments. Dry climates, heating & air conditioning, reading & television, and other lifestyle or environmental factors can affect the health of one’s eyes.

If these glands become blocked or fail due to aging or changes in your health, your tears won’t perform the way they should causing the dry, scratchy, and uncomfortable sensations associated with Dry Eye. Meibomian gland disease (MGD) is the leading cause of dry eye. If MGD is the cause of your dry eye, then your optometrist may recommend an advanced, painless treatment called LipiFlow.

The Procedure

LipiFlow is a proven treatment for dry eye that helps to restore the natural moisture balance for your eyes. It is a non-invasive treatment that targets meibomian gland disease. The LipiFlow is specially designed to remove blockages and restore the functionality of the Meibomian glands, allowing for the regular production of the oils. LipiFlow works by safely and comfortably delivering a combination of heat and therapeutic motion to the eyelids to open the passages found in the Meibomian glands.

The LipiFlow device utilizes patented components called Activators that are attached to the eyelids during the 12-minute treatment session. Sterile and single-use, the Activators are designed for patient safety and comfort. They are designed to prevent any transfer of heat or pressure onto the eyeball itself and are contoured to prevent contact with the cornea, protecting the structure of the eye. This state-of-the-art therapy opens blocked ducts and restores gland function.

The Benefits

  • The LipiFlow treatment is noninvasive and performed in-office and completed in a single office visit.
  • Treatments are painless and symptoms improve in as little as two weeks.
  • Each treatment takes about 12 minutes
  • Most patients find improvement from symptoms in as little as two weeks
Thomas Eye Group